Table 2.
Variables | RFS | OS | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariable analysis | Univariate analysis | Multivariable analysis | |||||||||
HR | 95% CI | p value | HR | 95% CI | p value | HR | 95% CI | p value | HR | 95% CI | p value | |
Age: ≥50 vs <50 | 2.74 | 1.43–5.24 | 0.002 | 2.54 | 1.32–4.89 | 0.005 | 2.66 | 1.42–4.96 | 0.002 | 2.35 | 1.25–4.43 | 0.008 |
Grade: III vs I + II | 1.89 | 1.04–3.46 | 0.038 | 1.89 | 1.06–3.40 | 0.032 | ||||||
Stage: III + IV vs I + II | 1.74 | 0.94–3.23 | 0.08 | 2.81 | 1.62–4.89 | 0.001 | 2.38 | 1.36–4.17 | 0.002 | |||
ER: (+) vs (−) | 0.63 | 0.36–1.08 | 0.09 | 1.13 | 0.65–1.97 | 0.66 | ||||||
PR: (+) vs (−) | 0.59 | 0.34–1.03 | 0.06 | 0.79 | 0.45–1.38 | 0.40 | ||||||
HER2: (+) vs (−) | 0.86 | 0.49–1.50 | 0.59 | 0.88 | 0.51–1.51 | 0.64 | ||||||
TMCC3 Tumor: high vs low | 3.32 | 1.89–5.83 | 0.001 | 2.81 | 1.45–5.45 | 0.002 | 2.92 | 1.69–5.02 | 0.001 | 2.28 | 1.31–3.96 | 0.004 |
RFS relapse-free survival, OS overall survival, HR hazard ratio, CI confidence interval.
Bold values indicate statistical significance p < 0.05.